Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients

The lifespan of schizophrenia (SCZ) patients is considered 25 years shorter compared to the general population, primarily due to cardiovascular (CV) disease. This study aims to assess the CV profile of the SCZ inpatients from Psychiatry Clinic I and II of Cluj-Napoca between 2018-2019. Methods: The...

Full description

Saved in:
Bibliographic Details
Main Authors: Cosmin-Ioan MOGA, Ioana Valentina MICLUTIA, Catalina Angela CRISAN, Mihaela FADYGAS-STANCULETE
Format: Article
Language:English
Published: Bucharest College of Physicians 2023-01-01
Series:Modern Medicine
Subjects:
Online Access:https://medicinamoderna.ro/wp-content/uploads/2023/06/Estimation-of-Cardiovascular-Risk-by-Framingham-Score-in-a-Cross-sectional-Sample-of-Schizophrenia-Inpatients.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850259928073109504
author Cosmin-Ioan MOGA
Ioana Valentina MICLUTIA
Catalina Angela CRISAN
Mihaela FADYGAS-STANCULETE
author_facet Cosmin-Ioan MOGA
Ioana Valentina MICLUTIA
Catalina Angela CRISAN
Mihaela FADYGAS-STANCULETE
author_sort Cosmin-Ioan MOGA
collection DOAJ
description The lifespan of schizophrenia (SCZ) patients is considered 25 years shorter compared to the general population, primarily due to cardiovascular (CV) disease. This study aims to assess the CV profile of the SCZ inpatients from Psychiatry Clinic I and II of Cluj-Napoca between 2018-2019. Methods: The following indicators were documented from interview and laboratory data: arterial hypertension (AHT), smoking, dyslipidemia, obesity, metabolic syndrome (MS), medication adherence (MA), Framingham score (FS), and CV diagnosis (CVd). The sample was separated into two groups based on FS and CV diagnosis: high-risk/CVd and medium/low-risk. Results: 50 SCZ patients were included in the study. 58% had AHT and 10% were prediagnosed, 90% had lipids perturbations of which 26.7% were prediagnosed, 66 % met the criteria for MS from which one prediagnosis, 12% had a CVd and the average FS was 12.7% corresponding to intermediate risk category. MA subjects had a lower risk to be in the high risk/CVd group (OR=1/0.22, p=0.02) and no association was found for the gender-CV risk categories (p=0.08). Conclusion: 1. The known CV risk factors are underdiagnosed in SCZ patients 2. SCZ might attenuate the gender CV risk stratification; and 3. MA might decrease the CV risk in SCZ.
format Article
id doaj-art-ddab2f3188f345f396bf08aec0d32feb
institution OA Journals
issn 1223-0472
2360-2473
language English
publishDate 2023-01-01
publisher Bucharest College of Physicians
record_format Article
series Modern Medicine
spelling doaj-art-ddab2f3188f345f396bf08aec0d32feb2025-08-20T01:55:45ZengBucharest College of PhysiciansModern Medicine1223-04722360-24732023-01-01302101110https://doi.org/10.31689/rmm.2023.30.2.101Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia InpatientsCosmin-Ioan MOGA0https://orcid.org/0000-0003-2521-1421Ioana Valentina MICLUTIA1https://orcid.org/0000-0003-2478-0876Catalina Angela CRISAN2Mihaela FADYGAS-STANCULETE3Department of Psychiatry, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Psychiatry, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Psychiatry, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Psychiatry, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, RomaniaThe lifespan of schizophrenia (SCZ) patients is considered 25 years shorter compared to the general population, primarily due to cardiovascular (CV) disease. This study aims to assess the CV profile of the SCZ inpatients from Psychiatry Clinic I and II of Cluj-Napoca between 2018-2019. Methods: The following indicators were documented from interview and laboratory data: arterial hypertension (AHT), smoking, dyslipidemia, obesity, metabolic syndrome (MS), medication adherence (MA), Framingham score (FS), and CV diagnosis (CVd). The sample was separated into two groups based on FS and CV diagnosis: high-risk/CVd and medium/low-risk. Results: 50 SCZ patients were included in the study. 58% had AHT and 10% were prediagnosed, 90% had lipids perturbations of which 26.7% were prediagnosed, 66 % met the criteria for MS from which one prediagnosis, 12% had a CVd and the average FS was 12.7% corresponding to intermediate risk category. MA subjects had a lower risk to be in the high risk/CVd group (OR=1/0.22, p=0.02) and no association was found for the gender-CV risk categories (p=0.08). Conclusion: 1. The known CV risk factors are underdiagnosed in SCZ patients 2. SCZ might attenuate the gender CV risk stratification; and 3. MA might decrease the CV risk in SCZ.https://medicinamoderna.ro/wp-content/uploads/2023/06/Estimation-of-Cardiovascular-Risk-by-Framingham-Score-in-a-Cross-sectional-Sample-of-Schizophrenia-Inpatients.pdfschizophreniacardiovascularframingham scorecomorbiditiesmetabolic syndrome
spellingShingle Cosmin-Ioan MOGA
Ioana Valentina MICLUTIA
Catalina Angela CRISAN
Mihaela FADYGAS-STANCULETE
Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients
Modern Medicine
schizophrenia
cardiovascular
framingham score
comorbidities
metabolic syndrome
title Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients
title_full Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients
title_fullStr Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients
title_full_unstemmed Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients
title_short Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients
title_sort estimation of cardiovascular risk by framingham score in a cross sectional sample of schizophrenia inpatients
topic schizophrenia
cardiovascular
framingham score
comorbidities
metabolic syndrome
url https://medicinamoderna.ro/wp-content/uploads/2023/06/Estimation-of-Cardiovascular-Risk-by-Framingham-Score-in-a-Cross-sectional-Sample-of-Schizophrenia-Inpatients.pdf
work_keys_str_mv AT cosminioanmoga estimationofcardiovascularriskbyframinghamscoreinacrosssectionalsampleofschizophreniainpatients
AT ioanavalentinamiclutia estimationofcardiovascularriskbyframinghamscoreinacrosssectionalsampleofschizophreniainpatients
AT catalinaangelacrisan estimationofcardiovascularriskbyframinghamscoreinacrosssectionalsampleofschizophreniainpatients
AT mihaelafadygasstanculete estimationofcardiovascularriskbyframinghamscoreinacrosssectionalsampleofschizophreniainpatients